| Teva Pharmaceutical Industries Limited (TEVA) | |||
|---|---|---|---|
| 18.46 -0.56 (-2.94%) | 12-14 16:01 | ||
| Open: | 18.86 | Pre. Close: | 19.02 |
| High: | 19.16 | Low: | 18.28 |
| Volume: | 9,608,849 | Market Cap: | 18806M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 19.171 - 19.269 | 19.269 - 19.344 |
| Low: | 18.058 - 18.158 | 18.158 - 18.235 |
| Close: | 18.301 - 18.469 | 18.469 - 18.598 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 25.62 One year: 28.58 |
| Support: | Support1: 17.83 Support2: 14.83 |
| Resistance: | Resistance1: 21.93 Resistance2: 24.47 |
| Pivot: | 20.41 |
| Moving Averages: | MA(5): 18.68 MA(20): 20.84 MA(100): 22.16 MA(250): 21.03 |
| MACD: | MACD(12,26): -0.91 Signal(12,26,9): -0.60 |
| %K %D: | %K(14,3): 14.96 %D(3): 14.16  |
| RSI: | RSI(14): 27.56 |
| 52-Week: | High: 25.96 Low: 16.35 Change(%): -0.8 |
| Average Vol(K): | 3-Month: 1114791 10-Days: 1237635 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.TEVA has closed above bottom band by 15.3%. Bollinger Bands are 49.7% wider than normal. The large width of the bands suggest high volatility as compared to TEVA's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
2018-12-15T09:12:29-05:00 Stocks To Watch: Time To Connect The Dots |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability |  |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency | |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Specialty Generic | |
| Shares Out. (M) | 1018.73 |
| Shares Float (M) | 1016.31 |
| % Held by Insiders | 0.20 |
| % Held by Institutions | 110.20 |
| Shares Short (K) | 34763 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | 3.210 |
| EPS Est. Current Year | 4.230 |
| EPS Est. Next Year | 3.690 |
| EPS Est. Next Quarter | 1.090 |
| Forward EPS | 2.790 |
| Book Value (p.s.) | 1.480 |
| PEG Ratio | -0.94 |
| Profit Margin | -57.30 |
| Operating Margin | 16.32 |
| Return on Assets (ttm) | -14.6 |
| Return on Equity (ttm) | -52.0 |
| Qtrly Rev. Growth | -19.4 |
| Gross Profit (p.s.) | 2.495 |
| Sales Per Share | |
| EBITDA (p.s.) | -12.279 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | 4220.00 |
| Levered Free Cash Flow (M) | 4360.00 |
| Stock Valuation | |
|---|---|
| P/E | 5.75 |
| P/E Growth Ratio | -0.03 |
| P/BV | 12.47 |
| P/S | 973085184.00 |
| P/CF | 4.46 |
| Dividend Yield | |
| Dividends & Splits | |
|---|---|
| Dividend | |
| Dividend Pay Date | 2017-12-12 |
| Ex-Dividend Date | 2017-11-27 |
| Forward Dividend | |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
